Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness

CompletedOBSERVATIONAL
Enrollment

1,068

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 6, 2025

Study Completion Date

March 6, 2025

Conditions
Pediatric or Young Adult Cancer Survivors
Interventions
GENETIC

Family History Questionnaire (FHQ)

"Consented subjects will be given the Family History Questionnaire (FHQ) to complete either in clinic or at home. Subjects who chose to complete the FHQ at home will be given a stamped envelope with a label. For participants who are children and cannot fill out the questionnaire on their own, the clinic RSA will instruct the parent, guardian, or legally authorized representative (LAR) present to fill out the questionnaire, reminding them that the You in the questionnaire refers to their child."

GENETIC

Salvia sample

The saliva samples will be collected in Oragene DNA Self-Collection Kits or a similar product. Patients will be instructed to donate about 2ml of saliva into a vial, which contains 2ml of product. Oragene or similar solution.

OTHER

Blood sample

Subjects will be offered the option of a blood collection instead of saliva. For adult subjects who opt for blood collection, two tubes of blood (approximately 20cc) will be drawn from the utilizing a sterile technique. For subjects under the age of 18 who opt for blood collection, approximately 3-5cc of blood will be collected utilizing a sterile technique.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01667952 - Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness | Biotech Hunter | Biotech Hunter